UK recommends offering persons under 30 yrs an alternative to AstaZeneca jab if possible

A UK government committee advising on coronavirus vaccinations has recommended offering most people aged under 30 an alternative to the AstraZeneca jab if possible, due to heightened concerns over blood clots.

The change to the country’s so far highly successful COVID-19 vaccine programme comes after the medicines regulator reviewed data following dozens of blood clot incidents among people who had received the shot.

Britain’s medicines regulator said their review had found 79 blood clots and 19 deaths among people who had received at least one of the 20 million AstraZeneca doses administered in the UK.